Choosing a CAR for Relapsed/Refractory Large B-cell Lymphoma

被引：1
|
作者：
Abramson, Jeremy S. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
来源：
TRANSPLANTATION AND CELLULAR THERAPY | 2022年 / 28卷 / 10期
关键词：
AXICABTAGENE CILOLEUCEL; TISAGENLECLEUCEL; OUTCOMES; MULTICENTER;
D O I：
10.1016/j.jtct.2022.09.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：621 / 622
页数：2
相关论文
共 50 条
  • [31] Lisocabtagene Maraleucel Approved for Use in Relapsed/Refractory Large B-Cell Lymphoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 175 - 175
  • [32] Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma
    Graf, Solomon A.
    Cassaday, Ryan D.
    Morris, Karolyn
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Behnia, Sanaz
    Lynch, Ryan C.
    Krakow, Elizabeth
    Rasmussen, Heather
    Chauncey, Thomas R.
    Kanan, Sandra
    Soma, Lorinda
    Smith, Stephen D.
    Gopal, Ajay K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 176 - 181
  • [33] Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Juarez-Salcedo, Luis Miguel
    Nimkar, Santosh
    Corazon, Ana Maria
    Dalia, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [34] Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Shingleton, Jennifer R.
    Dave, Sandeep S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 166 - +
  • [35] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [36] Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma
    Nath, Karthik
    Wudhikarn, Kitsada
    Alarcon Tomas, Ana
    Perales, Miguel-Angel
    EXPERT OPINION ON DRUG SAFETY, 2023, : 5 - 15
  • [37] Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Barca, Eva Gonzalez
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [38] ABCs of ADCs in management of relapsed/refractory diffuse large B-cell lymphoma
    Alderuccio, Juan Pablo
    Sharman, Jeff P.
    BLOOD REVIEWS, 2022, 56
  • [39] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [40] Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease
    Matasar, Matthew J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1327 - 1330
12345